Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ANIK stock: Anika Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$53.39
Market Cap
804M
Sector
Health Care
Div. Growth
-
P/E
26.3
P/B
3.33
P/S
7.2
Dividend %
-
P/CF
29.1
P/FCF
27.5
Op. Cash Flow
38.5K
FCF
2.0
Op. Margin
42.50%
Net Margin
27.60%
ROE
13.70%
ROI
14.50%
ROA
12.70%
EPS Growth
-9.40%
Current Ratio
19.4
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Digirad Corporation (DRAD) $2.45 - 11.00% 40M Strong Buy
Accuray Incorporated (ARAY) $4.80 - - 381.1M Strong Buy
Brainstorm Cell Therapeutics I (BCLI) $4.13 - - 82.2M Strong Buy
Pen Inc (PENC) $1.30 - - 4M Strong Buy
IRIDEX Corporation (IRIX) $7.72 - - 98.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More